Wednesday, September 7, 2016

Milan allies kill cheaper competition with false claims

Good ol’ Milan Pharmaceuticals, always looking out for the health of West Virginians.

When Auvi-Q, the talking auto-injector that was the Siri of the food allergy world, came along instructing parents and patients how to handle the life-saving injection, Milan Big Pharma sued to prevent the competition.

Miraculously, 26 reports of the device not working surfaced. Not one was verified. But it shut down the Auvi-Q production and Milan lined its pockets with zillions of dollars and put thousands of lives at increased risk.

When the West Virginia Department of Health and Human Resources tried to switch to the cheaper (of course) Auvi-Q instead of the Epi-Pen that paid CEO Heath Bresch $19 million in 2015, Milan sued to block the change. But lost.

West Virginia Medicare, West Virginia Public Employees’ Insurance Agency and the Children’s Health Insurance Program all switched to Auvi-Q. Seven months later, using the false claims of malfunctions of Auvi-Q, the method was recalled.

Voila! Milan was back gouging the taxpayers with its Epi-Pens.

If another company did that, do you think West Virginia’s Senator Joe Manchin would be silent? Let me put it another way: If Joe’s daughter wasn’t the Milan CEO, do you think Joe would be making political hay by attacking Milan?

Other members of Congress are investigating whether Mylan violated antitrust law. Except for Joe Manchin, of course.

Milan spent $1.2 million to lobby for its Epi-Pens with politicians. That was money well spent since Milan raised the Epi-Pens’ price from $56.64 to $317.82, which would be equivalent to you getting a pay raise ALMOST SIX TIMES your current salary. All at the expense of the health of children and adults who need the life-saving device the most.

No comments:

Post a Comment